Roth Capital Markets has initiated coverage of Microbot Medical with a “Buy” rating and a US $5.50 price target ...

Roth Capital analyst Kyle Bauser initiated coverage of Microbot Medical (MBOT) with a Buy rating and $5.50 price target The firm says the ...

Liberty is a remotely operated robotic system for peripheral endovascular procedures and has received FDA clearance.

Microbot Medical says Emory University Hospital in Atlanta is the first worldwide to embrace its Liberty endovascular robotic ...

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, announced that Emory University Hospital, a nationally recognized academic ...

Despite delays to the $1B inpatient tower, UIHC is pursuing $40M for 3 three modernization projects to improve operating room ...

Liberty Mutual brings a fleet-first approach to commercial auto, pairing coverage breadth with risk-control support and modern claims handling. For trucking companies that want mainstream carrier ...

SOUTH LAKE TAHOE, Calif. – Liberty’s Commercial Incentive Program is more than just a rebate opportunity; it’s a long-term business advantage. The program helps commercial customers offset the upfront ...

Harel Gadot, CEO of Microbot Medical Inc. (NASDAQ:MBOT), was recently a guest on Benzinga's All Access. Microbot Medical makes the LIBERTY® Endovascular Robotic System, a single-use, fully disposable ...

Men's clothing retailer State and Liberty Clothing Co. will open its first Wisconsin store in Milwaukee. The new location is planned for winter 2025 in the Historic Third Ward at 333 N. Broadway.

Microbot Medical Inc., the developer of the LIBERTY Endovascular Robotic System, today said the Japanese Patent Office has granted the company its first patent in Japan. The patent covers the core ...